Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| NEEDHAM INVESTMENT MANAGEMENT LLC | RSSS Research Solutions, Inc. | 13G | 5.21% | Feb 13, 2024 | 2y |
| BioNTech SE | AUTL Autolus Therapeutics plc | 13D | 12.5% | Feb 13, 2024 | 2y |
| Starboard Value LP | ALIT Alight, Inc. / Delaware | 13D | 7.8% | Feb 13, 2024 | 2y |
| Orin Hirschman | BWAY Brainsway Ltd. | 13G/A | 4.1% | Feb 13, 2024 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares | 13G/A | 0.3% | Feb 1, 2024 | 2y |
| Group of Trophy, LLC | GIPR Generation Income Properties, Inc. | 13G | 6.8% | Jan 31, 2024 | 2y |
| Darin Feinstein | CORZ Core Scientific, Inc. | 13D/A | 9.4% | Jan 23, 2024 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | TCOA Zalatoris Acquisition Corp. | 13G/A | 2.75% | Jan 14, 2024 | 2y |
| Fahar Merchant | MDNAF Medicenna Therapeutics Corp. | 13G/A | 29.1% | Dec 31, 2023 | 2y |
| Zalupski Patrick O. | DFH Dream Finders Homes, Inc. | 13G | 65.6% | Dec 31, 2023 | 2y |
| Lovett William Radford II | DFH Dream Finders Homes, Inc. | 13G | 15.4% | Dec 31, 2023 | 2y |
| ATLANTIC FAMILY WEALTH, LLC | ABI Victory Portfolios II | 13G | 5.7% | Dec 31, 2023 | 2y |
| Raymond T. Hyer | HRTG Heritage Insurance Holdings, Inc. | 13G/A | 13.75% | Dec 31, 2023 | 2y |
| Reagan Lovig | AVNI Arvana Inc | 13G | 5.56% | Jan 3, 2023 | 2y |
| Fredric N. Eshelman | GTHX G1 Therapeutics, Inc. Common Stock | 13D/A | 9.26% | Nov 18, 2022 | 2y |
| Lynne E. Peterson | ELSE Electro Sensors Inc | 13D/A | 10.2% | Dec 30, 2021 | 2y |
| BT Parent GP, LLC | RPAY Repay Holdings Corp | 13D | 9.41% | Feb 20, 2024 | 2y |
| Oasis Management Co Ltd. | STRS Stratus Properties Inc | 13D/A | 14.5% | Feb 20, 2024 | 2y |
| Runa Capital Opportunity I (GP) | MRDB MariaDB plc | 13D/A | 4% | Feb 17, 2024 | 2y |
| Saba Capital Management, L.P. | MPA Blackrock Muniyield Pennsylvania Quality Fund | 13D/A | 15.5% | Feb 16, 2024 | 2y |
| Saba Capital Management, L.P. | BMEZ BlackRock Health Sciences Term Trust | 13D/A | 17.94% | Feb 16, 2024 | 2y |
| Saba Capital Management, L.P. | ECAT BlackRock ESG Capital Allocation Term Trust | 13D/A | 25.89% | Feb 16, 2024 | 2y |
| Socrates Trust | APO Apollo Global Management, Inc. | 13D/A | 5.8% | Feb 16, 2024 | 2y |
| L. W. Van Loan Trust dated September 8, 2006 | AP Ampco Pittsburgh Corp | 13D/A | 4.9% | Feb 16, 2024 | 2y |
| Saba Capital Management, L.P. | MYN Blackrock Muniyield New York Quality Fund, Inc. | 13D/A | 5.4% | Feb 16, 2024 | 2y |
| BLACK, LEON D | APO Apollo Global Management, Inc. | 13D/A | 7.9% | Feb 16, 2024 | 2y |
| Saba Capital Management, L.P. | BCAT BlackRock Capital Allocation Term Trust | 13D/A | 13.56% | Feb 16, 2024 | 2y |
| Chad Richison | PAYC Paycom Software, Inc. | 13D/A | 11.8% | Feb 16, 2024 | 2y |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | BB BLACKBERRY Ltd | 13D/A | 8.1% | Feb 15, 2024 | 2y |
| Saba Capital Management, L.P. | BTX BlackRock Technology & Private Equity Term Trust | 13D/A | 21.66% | Feb 15, 2024 | 2y |
| Elliott Investment Management L.P. | BTU Peabody Energy Corp | 13D/A | 7.3% | Feb 15, 2024 | 2y |
| Sessa Capital (Master), L.P. | GTX Garrett Motion Inc. | 13G/A | 10.6% | Feb 15, 2024 | 2y |
| CYRUS CAPITAL PARTNERS, L.P. | ICMB Investcorp Credit Management BDC, Inc. | 13D/A | 6.3% | Feb 15, 2024 | 2y |
| Saba Capital Management, L.P. | BSTZ BlackRock Science & Technology Term Trust | 13D/A | 6.28% | Feb 15, 2024 | 2y |
| Camac Partners, LLC | ABCP AmBase Corp | 13D/A | 10.4% | Feb 15, 2024 | 2y |
| PAVmed Inc. | LUCD Lucid Diagnostics Inc. | 13D/A | 65.2% | Feb 15, 2024 | 2y |
| Phoenix Financial Ltd. | SMWB Similarweb Ltd. | 13G/A | 4.88% | Feb 15, 2024 | 2y |
| Jurgen van de Vyver | CERO Cero Therapeutics Holdings, Inc. | 13D/A | 6.8% | Feb 14, 2024 | 2y |
| RS Fund LP | NURO NeuroMetrix, Inc. Common Stock | 13G | 14.4% | Feb 13, 2024 | 2y |
| Max Gottschalk | PMNT Perfect Moment Ltd. | 13D | 23% | Feb 12, 2024 | 2y |
| Harraden Circle Investments, LLC | CPTKW Crown PropTech Acquisitions | 13G | 9.99% | Feb 12, 2024 | 2y |
| GILEAD SCIENCES, INC. | KYTX Kyverna Therapeutics, Inc. | 13G | 9.6% | Feb 12, 2024 | 2y |
| David B. Blundin | EVER EverQuote, Inc. | 13D/A | 28.3% | Feb 9, 2024 | 2y |
| Trung T. Doan | LEDS SemiLEDs Corp | 13D/A | 17.89% | Feb 9, 2024 | 2y |
| Luxor Capital Group, LP | FIP FTAI Infrastructure Inc. | 13G | 5% | Feb 9, 2024 | 2y |
| Mike Edward McAleer | SYRA Syra Health Corp | 13G | 0% | Feb 8, 2024 | 2y |
| Quint Digital Ltd | LEE LEE ENTERPRISES, Inc | 13G | 8.4% | Feb 8, 2024 | 2y |
| S.H.N. Financial Investments Ltd. | TENX Tenax Therapeutics, Inc. | 13G | 5.6% | Feb 8, 2024 | 2y |
| MMCAP International Inc. SPC | ASTL Algoma Steel Group Inc. | 13G | 6.5% | Feb 7, 2024 | 2y |
| TCG Crossover GP I, LLC | KALV KalVista Pharmaceuticals, Inc. | 13D/A | 6.52% | Feb 7, 2024 | 2y |